Sr. Test Engineer at Endpoint Clinical (Bengaluru, India)

Endpoint Clinical· Bengaluru, India·17h ago

Role details

Work type

Hybrid

Employment

Full-Time

Level

Senior

Job description

The full description lives on the employer’s site. Open the listing.

Culture: Endpoint Clinical emphasizes a culture of excellence, accountability, and collaboration. They want to be a "top career destination" [endpointclinical.com].
Awards: Recognized by Built In as a Top 100 Midsize Place to Work from 2021 to 2025 [endpointclinical.com].
Work Policy: Employs a hybrid work model with flexible on-site expectations. Offices are located globally including the US (Raleigh, MA), Europe, and Asia [builtin.com, endpointclinical.com].
Global Team: A workforce of over 600 people spread across 10 countries (including India, US, UK, Philippines, China), fostering a collaborative, global culture [linkedin.com, endpointclinical.com].
Benefits: Offers performance bonuses, generous parental leave, family medical leave, dental insurance, Flexible Spending Account (FSA), and customized development tracks [builtin.com].
Engineering & Innovation: The company is focused on next-generation technology and AI, indicating a dynamic and challenging environment for technical talent [endpointclinical.com].
Note on Employee Sentiment: The current employee rating on LinkedIn is 2.9/5.0 (based on 177 reviews), with culture and career opportunities rated lower (2.5/5.0) [linkedin.com]. This is an important data point to consider.

One-liner: Endpoint Clinical provides Randomization and Trial Supply Management (RTSM) technology and services to clinical trial sponsors and CROs, helping them manage complex global trials efficiently.
Entity Type: Private
Headquarters: Raleigh, North Carolina, United States
Founded: 2009
Founders: Not publicly available

Primary industry/industries: Life Sciences / Clinical Trial Technology (RTSM/IRT)
Target customers: B2B – Biopharmaceutical companies (from emerging biotech to 8 of the Top 15), Contract Research Organizations (CROs)
Mission or purpose statement: To help set the foundation for clinical trial success by delivering innovative, high-quality RTSM solutions that make a difference in advancing lifesaving treatments.

[PULSE®]: A fully customizable and adaptive dynamic RTSM platform designed to scale with trial workflow and deliver real-time responsiveness for evolving needs. (SaaS/Platform)
[Elosity]: A multi-tenant, robust RTSM platform offering enhanced speed, flexibility, and AI-driven capabilities to optimize trial logistics and patient outcomes. (SaaS/Platform)
RTSM Support & SLAs: Proactive, expert-led support with defined service level agreements to keep trials running smoothly. (Service)
AI Services: Harnessing AI-driven insights to streamline eClinical operations and enable smarter decision-making across global trials. (Service)
UAT Services: Comprehensive, independent User Acceptance Testing to ensure flawless RTSM performance and accelerate study timelines. (Service)
Consulting Services: Expert consulting on randomization and drug supply strategies to enhance trial integrity and optimize resource allocation. (Service)

Valuation/Market Cap: Not publicly available
Key Metric: Annual Revenue of $65.6M (estimated) [linkedin.com]
Total Funding: $1.7M [linkedin.com]
Notable Investors/Partners: Not publicly disclosed. Partners with 300+ sponsors including 8 of the Top 15 Biopharma leaders [endpointclinical.com].
Growth Signals:
- Recognized as an RTSM Leader in the Everest Group 2025 PEAK Matrix® Assessment [endpointclinical.com].
- Powers trials across 90+ countries and works with 100,000+ clinical trial sites [endpointclinical.com].
- Has supported over 1M patients across 2,000+ clinical studies [endpointclinical.com].
- Headcount of ~486-600 employees, with a modest growth of 0.5% YoY [linkedin.com, endpointclinical.com].

Deep RTSM Expertise: Nearly 20 years of RTSM advancement and 200+ years of combined industry experience on the leadership team [endpointclinical.com].
Proven Scale & Reliability: Demonstrated ability to support complex, adaptive trials across a wide range of therapeutic areas (20+) including oncology and rare diseases [endpointclinical.com].
Governance-First Approach: Built-in controls, audit readiness, and regulatory alignment provide a strong quality and compliance mindset [endpointclinical.com].
Leadership Recognition: Named a Leader by the Everest Group, a highly respected industry analyst firm [endpointclinical.com].

Innovation & AI: Integrating AI-driven capabilities into platforms (Elosity) to optimize trial logistics and improve patient outcomes [endpointclinical.com].
Global Expansion: Continuing to support trials globally across 90+ countries [endpointclinical.com].
Operational Excellence: Maintaining a strong focus on quality, compliance, and proactive support as key differentiators [endpointclinical.com].

Sources